Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioEnterprise ValueInventory AverageInvested Capital

Mesoblast (MESO) EBIT Margin (2016 - 2023)

Historic EBIT Margin for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to 139089.06%.

  • Mesoblast's EBIT Margin rose 57957100.0% to 139089.06% in Q2 2023 from the same period last year, while for Jun 2023 it was 8913.69%, marking a year-over-year increase of 87919100.0%. This contributed to the annual value of 360.79% for FY2025, which is 6353800.0% up from last year.
  • Latest data reveals that Mesoblast reported EBIT Margin of 139089.06% as of Q2 2023, which was up 57957100.0% from 60282.57% recorded in Q1 2023.
  • Mesoblast's EBIT Margin's 5-year high stood at 353505.73% during Q2 2021, with a 5-year trough of 81291.64% in Q1 2021.
  • Moreover, its 5-year median value for EBIT Margin was 14163.98% (2020), whereas its average is 27998.87%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2020, then crashed by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows Mesoblast's EBIT Margin stood at 33300.91% in 2019, then skyrocketed by 101bps to 447.52% in 2020, then tumbled by -9274bps to 41057.28% in 2021, then increased by 5bps to 38887.07% in 2022, then surged by 458bps to 139089.06% in 2023.
  • Its last three reported values are 139089.06% in Q2 2023, 60282.57% for Q1 2023, and 38887.07% during Q4 2022.